Citations with the tag: BIOSITE Inc
Results 1 - 50
- BioSite, Inc.
// San Diego Business Journal; 5/20/2002, Vol. 23 Issue 20, p35
Features Biosite, Inc., a research-based diagnostic company in San Diego, California. Performance record of the company; Directors and career background; Compensations of executives.
- Heart Disease Tests a Niche for Biosite.
Webb, Marion // San Diego Business Journal; 5/26/2003, Vol. 24 Issue 21, p9
Reports on the introduction of blood tests for the detection of heart disease by Biosite Inc. in San Diego, California. Usability of the tests; Projections on the revenue from the tests; Features of the tests.
- Firm Aims to Corner Market With Point-of-Care Tests.
Webb, Marion // San Diego Business Journal; 8/27/2001, Vol. 22 Issue 35, p1
Reports the plan of Biosite Inc. to establish a point-of-care drug abuse test firm in San diego, California. Accounts on the use of drug abuse detector to increase corporate profit; Usability of rapid diagnosis; Clearance of the company for devices to diagnose heart attacks.
- Biosite, Inc.
Webb, Marion // San Diego Business Journal; 10/1/2001, Vol. 22 Issue 40, p33
Features the Biosite Inc., a research-based diagnostic company in San Diego, California. List of directors; Performance record; Executive compensation; Significant stock ownership.
- Biosite Stock Jumps After Patent Dispute Resolved.
Webb, Marion // San Diego Business Journal; 9/23/2002, Vol. 23 Issue 38, p19
Reports on the rise in shares of San Diego, California-based medical diagnostic company Biosite Inc. after the announcement that it had resolved disputes with Berkeley, California-based Xoma over patent and licensing issues. Stock figures; Settlement terms.
- Rapid, objective immunoassay.
Webb, Marion // MLO: Medical Laboratory Observer; May2008, Vol. 40 Issue 5, p50
The article evaluates the Triage BNP Test from Biosite.
- Author Applauds Biosite's Heart-Failure Test.
Webb, Marion // San Diego Business Journal; 8/5/2002, Vol. 23 Issue 31, p5
Presents updates on San Diego, California-based biotechnology firms Biosite Inc. and Digirad Corp. as of August 5, 2002. Use of Biosite's test to help emergency room doctors to diagnose congestive failure; Use of Digirad's dual-head camera system to detect heart disease.
Webb, Marion // San Diego Business Journal; 4/18/2005, Vol. 26 Issue 16, p30
The article presents a information on San Diego public stocks. Some of the companies listed in the article are: Gen Probe Inc.; ResMed Inc.; Biosite Inc.; Invitrogen Corp. and Cypress Biosciences Inc.
- Beckman CEO Sees Growth in Heart Tests, Sans Biosite.
Reed, Vita // Orange County Business Journal; 5/28/2007, Vol. 30 Issue 22, p1
The article reports on the statements made by Scott Garrett, chief executive officer of Beckman Coulter Inc., after giving up the $1.6 billion acquisition bid for Biosite Inc. in Orange County, California. Garrett points out that the company is capable of growing without acquiring Biosite Inc....
- Tox Testing for Drugs of Abuse and Therapeutic Monitoring.
Rose, Shannon // Clinical Lab Products; Sep2009, Vol. 39 Issue 9, p18
The article focuses on the need for rapid testing of drugs of abuse in the diagnosis of patients. The simple-to-run Triage TOX Drug Screen Panel system from Biosite reportedly uses fluorescence immunoassay to provide 11 drug screen results at the same time in 15 minutes. It is stated that test...
- Facility Fosters Functionality For Life Sciences Firm.
Weeks, Katie // San Diego Business Journal; 6/26/2006, Vol. 27 Issue 26, pA27
The article informs that Biosite Inc. has build a four-building, $300 million-plus campus in Sorrento Valley, California. The campus has reflected its culture through the Bauhaus architecture style. According to Kim Blickenstaff, CEO of Biosite, the company is looking for sort of an innovative,...
- BIOTECHNOLOGY COMPANIES.
Weeks, Katie // San Diego Business Journal; Lists Supplement, p106
Lists the top biotechnology companies in San Diego, California as ranked by total local employees as of May 1, 2004. Biosite Inc.; Gen-Probe Inc.; Amylin Pharmaceuticals Inc.
- One-hour drug screen.
Weeks, Katie // Crain's Small Business -- Chicago Edition; Nov96, Vol. 4 Issue 9, p34
Reports that Rush Occupational Health of Chicago, Illinois, and Biosite Technologies of San Diego, California, are offering a drug screen that can report negative results in one hour. Information on the Express Test; Where the blood specimen is sent; Accuracy of the drug screen; Names of...
- Beckman Gives Up Biosite to the Relief of Wall Street.
Reed, Vita // Orange County Business Journal; 5/21/2007, Vol. 30 Issue 21, p1
The article reports that Beckman Coulter Inc. was affected on a six-week bidding for the acquisition of Biosite Inc. in San Diego, California. Beckman's market value has decreased by 7% during its first offer for Biosite. According to R.W. Baird & Co.'s analysts Quintin Lai, the company has...
- EXECUTIVE SUMMARY.
Reed, Vita // Orange County Business Journal; 4/2/2007, Vol. 30 Issue 14, p9
The article offers news briefs in business in the California. Beckman Coulter Corp. is buying Biosite Inc. in San Diego for $1.5 billion. Clean Energy Fuels Inc. has increased its initial public offering in Seal Beach. The bankrupt mortgage lender People's Choice Home Loan Inc. will auction off...
Reed, Vita // San Diego Business Journal; 3/8/2004, Vol. 25 Issue 10, p16
Lists several manufacturers in California. Total employees of Kyocera Corp.; Contact information of Callaway Golf Co.; Products of Biosite Inc.
- Emphasize the Milestones When Pitching Venture Capitalists for Cash.
Weeks, Katie // San Diego Business Journal; 5/14/2007, Vol. 28 Issue 20, p3
The article reports on developments related to medical companies in San Diego County, California. Laura Shawver, chief executive officer (CEO) of Phenomix Corp., emphasized on the milestones of the company during company presentations for first-round venture capital financing in 2002. The...
- Fishing Chips.
Uehling, Mark D. // Bio-IT World; Sep2003, Vol. 2 Issue 9, p60
Discusses the potential of protein chips developed by biotechnology companies in the U.S. Ability of protein chips commercialized by Protometrix; Advantages of traditional protein-detection technologies of Biacore; Disadvantages of protein chips; Application of the technology at Biosite. ...
- Cheap blood test heralds speedy stroke diagnosis.
Westphal, Sylvia Pagán // New Scientist; 3/20/2004, Vol. 181 Issue 2439, p11
A quick and cheap blood test could soon help doctors tell if a patient is having a stroke and help them get the right treatment as soon as possible. Future versions might even be able to distinguish between different kinds of strokes. CT scans are good at spotting bleeds, but far less reliable...
- Biosite Construction Takes Shape at a New Mira Mesa Campus.
Thomas, Dave // San Diego Business Journal; 8/21/2006, Vol. 27 Issue 34, p25
The article reports on Delawie Wilkes Rodrigues Barker architectural design project for Biosite Inc. in Mira Mesa, San Diego, California. The original Biosite campus has a 180,000 feet of space located in Sorrento Valley and expansion plans for the new site in Mira Mesa call for nine buildings...
- Final Buyer of Biosite Remains an Unknown as Bidding War Continues.
Allen, Mike // San Diego Business Journal; 4/16/2007, Vol. 28 Issue 16, p6
The article reports on developments related to public companies in San Diego County, California. The board of directors of Biosite Inc. announced that it would begin negotiations with the company that offered an additional $5 per share over the past offer to purchase the medical device company....
- SAIC Reports Earnings, Names New Chief Operating Officer.
Allen, Mike // San Diego Business Journal; 9/17/2007, Vol. 28 Issue 38, p25
The article reports on developments related to public companies in San Diego County, California. SAIC Inc. reported financial performance with net profit of $131 million for the second quarter of 2006. Inverness Medical Innovations Inc, acquired Biosite Inc, for $1.8 billion. Ashworth Inc....
- Biosite Founder Establishes $1.5M Scholarship Fund.
Graves, Brad // San Diego Business Journal; 12/3/2007, Vol. 28 Issue 49, p11
The article focuses on the establishment of a $1.5 million scholarship fund by Biosite Inc. in San Diego, California. The fund will be managed by the Bessemer Trust and will benefit students of Blessed Sacrament Parish School. It is noted that the donation will fund the Brian's Scholars...
- TRIAGE STROKE PANEL PMA ACCEPTED FOR FDA REVIEW.
Graves, Brad // Biotech Business; Apr2005, Vol. 18 Issue 4, p7
Reports on the U.S. Food and Drug Administration's acceptance of the Triage Stroke Panel Premarket Approval Application filed by Biosite Inc. Description of the Triage Stroke Panel which will be used as an aid in the assessment and diagnosis of cerebral ischemia; Overview of the methods used to...
- Beckman's $1.67B Bid Finds Favor With Biosite.
Reed, Vita // Orange County Business Journal; 5/7/2007, Vol. 30 Issue 19, p1
The article reports on the move by Fullerton's Beckman Coulter Inc. and Inverness Medical Innovations Inc. to buy Biosite Inc. for $1.67 billion bid in the U.S. Biosite Inc., a San Diego maker of diagnostic tests, has offered a new bidding which is $5 a share higher than Beckman's original $1.55...
- Firm Gets OK to Market Heart Attack Monitor.
Reed, Vita // San Diego Business Journal; 3/10/2003, Vol. 24 Issue 10, p5
Reports that San Diego, California-based Biosite Inc. has won U.S. marketing clearance for a device to help doctors diagnose heart attacks.
- Biosite, Beckman Coulter Team Up to Market Blood Test.
Webb, Marion // San Diego Business Journal; 7/07/2003, Vol. 24 Issue 27, p14
Reports developments related to biotechnology industries in the U.S. as of July 2003. Agreement between medical device maker Biosite Inc. and Beckman Coulter Inc.; Amount of the government grant awarded to Vical Inc.; Details of the partnership between Illumina Inc. and the National Center for...
- SOB symptom panel.
Webb, Marion // MLO: Medical Laboratory Observer; Apr2006, Vol. 38 Issue 4, p34
The article evaluates the Triage Profiler Shortness of Breath Panel developed by Biosite Inc. which recognizes the SOB causes such as myocardial infarction, severity of congestive heart failure, and suspected disseminated intravascular coagulation including pulmonary embolism.
- Leading Companies in Health Care.
Webb, Marion // H&HN: Hospitals & Health Networks; Feb2005, Vol. 79 Issue 2, p90
Presents a directory of several advertisers representing top health care companies that serve the health care community in the U.S. American Association of Critical-Care Nurses; Biosite Inc.; Brother International.
- BIOSITE INC.
Webb, Marion // San Diego Business Journal; 4/4/2005, Vol. 26 Issue 14, p39
This article presents information on the stock performance and infrastructure of Biosite Inc. Biosite Inc. is a provider of medical diagnostics that help a physician diagnose diseases and health conditions. Biosite offers tests for drug screening, heart attack, congestive heart failure, acute...
- Week in Review.
Allen, Mike; Webb, Marion; Graves, Brad // San Diego Business Journal; 5/30/2005, Vol. 26 Issue 22, p43
The article offers business news briefs in San Diego, California for the week ending May 31, 2005. The city's unemployment rate dropped by four percent during the week. Diagnostic company Strategene Corp. has appointed Steve Martin as chief financial officer effective July 1. Science...
- Mergers & Acquisitions Update.
Allen, Mike; Webb, Marion; Graves, Brad // PharmaWatch: Biotechnology; Jun2007, Vol. 6 Issue 6, p17
No abstract available.
- WEEK IN REVIEW.
Allen, Mike; Webb, Marion; Graves, Brad // San Diego Business Journal; 12/6/2004, Vol. 25 Issue 49, p38
The article reports on top business news of the week November 26--December 2, 2004. It is reported that medical device firm Biosite Inc. recently was told by the U.S. Food and Drug Administration that its developed Triage D-Dimer Test to detect life-threatening blood clots has been cleared for...
- With IMI's close of Biosite buy, it also completes j-v deal with P&G.
Long, Don // Diagnostics & Imaging Week; 5/24/2007, Vol. 10 Issue 21, p1
The article reports that Inverness Medical Innovations (IMI) has purchased Biosite, and it has also formed a new joint venture company Procter & Gamble (P&G). IMI says it will collaborate with P&G to create SPD Swiss Precision Diagnostics GmbH, which will be based in Geneva, Switzerland. Kim...
- Shorter ED waits, fewer unnecessary admissions.
Thrall, Terese Hudson // H&HN: Hospitals & Health Networks; Jul2007, Vol. 81 Issue 7, pLS-6
The article focuses on the changes made by Texas-based John Peter Smith Hospital in its emergency department (ED). It notes that the hospital, in an effort to address the problem of overcrowding and unnecessary admissions for chest pain, decided to implement a new method to test blood for...
- WEEK IN REVIEW.
Thrall, Terese Hudson // San Diego Business Journal; 4/30/2007, Vol. 28 Issue 18, p50
The article reports on developments related to business enterprises in San Diego County, California. Cymer Inc. reported first quarter net profit of $20.3 million on revenue of $126.7 million. The San Diego U.S. Small Business Administration District and the Black Business Association have...
- Beckman Coulter Enters $1.55 Billion Biosite Deal.
Thrall, Terese Hudson // Bioworld Week; 4/2/2007, Vol. 15 Issue 14, p1
The article reports on the definitive merger agreement between Beckman Coulter Inc. and Biosite in the U.S. According to the author, the agreement allows Beckman to acquire all of Biosite's outstanding common stock in a cash tender offer of $85 a share, or roughly $1.55 billion on a fully...
- OTHER NEWS TO NOTE.
Thrall, Terese Hudson // BioWorld Today; 7/2/2007, Vol. 18 Issue 127, p2
The article offers news briefs on issues related to the pharmaceutical industry. Coley Pharmaceutical Group Inc. has granted Dynavax Technologies Corp. a nonexclusive license under its immunostimulatory oligonucleotide patent estate. Gene Network Sciences has entered a research collaboration...
- IMI on buying spree with $326.3M Cholestech deal.
Thrall, Terese Hudson // Medical Technology & Devices Week; 6/11/2007, Vol. 5 Issue 24, p3
The article focuses on the possible acquisition of Cholestech by Inverness Medical Innovations (IMI). The deal, which is valued at $326.3 million, follows the pending acquisition of Biosite. In March 2007, IMI bought 75% of the capital stock of Instant Technologies, then in February, the company...
- IMI's $90-a-share offer for Biosite tops bid by Beckman Coulter.
Johnson, Holland // Medical Device Daily; 4/6/2007, Vol. 11 Issue 66, p1
The article reports on Inverness Medical Innovations' (IMI) $90 per share offer to acquire Biosite. IMI, which currently owns about 4.9% of Biosite shares, sent an unsolicited letter to the company, indicating its intention to beat the $1.55 billion offer of Beckman Coulter by $5 a share....
- New Deal With Greek Officials Eases SAIC's Olympic-Size Headache.
Allen, Mike // San Diego Business Journal; 4/9/2007, Vol. 28 Issue 15, p8
The article offers news briefs related to business in San Diego, California. The billing disputes between Science Application International Corp. and the Greek government has been resolved through a new deal. Accredited Home Lenders Holding Co., a subprime lender company, has acquired a new...
Allen, Mike // BioPharm International; Feb2004, Vol. 17 Issue 2, p12
Reports on developments related to the pharmaceutical biotechnology industry in the U.S. as of February 2004. Approval granted by the Food and Drug Administration (FDA) to several new biotechnology drugs and biologics from BIO; Marketing approval given to the Triage BNP Test for Beckman Coulter...
- Beckman's Rich Offer Priced in Bidding War.
Reed, Vita // Orange County Business Journal; 4/9/2007, Vol. 30 Issue 15, p1
The article focuses on the $1.55 billion worth of premium-rich offer made by Beckham Coulter Inc. for Biosite Inc., a medical diagnostic company situated in San Diego, California. Chief Executive Scott Garrett claimed that the big deal was made to outbid other potential suitors. However, as...
- BIOTECHNOLOGY COMPANIES Ranked by local employees as of June 1, 2005.
Reed, Vita // San Diego Business Journal; 7/4/2005, Vol. 26 Issue 27, p19
Lists the top biotechnology companies in San Diego, California, ranked according to number of local employees as of June 1, 2005. Biosite Inc.; Amylia Pharmaceuticals Inc.; Gen-Probe Inc.; Ligand Pharmaceuticals Inc.; Scantibodies Clinical Laboratory Inc.; Neurocrine Biosciences Inc.; Diversa Corp.
- Product Pipeline.
Reed, Vita // Cardiovascular Devices & Drugs; Jun2009, Vol. 15 Issue 6, p23
The article reports that the Triage Cardiac Panel has been recalled by Biosite. The panel was developed to help healthcare professionals diagnose myocardial infarction. The product was recalled by the company because of minimal recovery of control samples that have creatine kinase MB. (CK-MB),...
- Summer 'dog days' filled with big deals.
Reed, Vita // Biomedical Business & Technology; Sep2007, Vol. 30 Issue 9, p17
the article reports mergers and acquisitions in the U.S. biomedical industry in July-August 2007. It includes the acquisitions of Dade Behring by Siemens, Digene by Qiagen, Biosite by Inverness Medical Innovations, and Kyphon by Medtronic. Meanwhile, Advanced Medical Optics withdrew its bid to...
- Screen Testing for Drugs of Abuse.
Gater, Laura // Courts Today; Oct/Nov2011, Vol. 9 Issue 5, p40
The article offers brief information on several products used by drug courts for testing drugs of abuse from Biosite Inc. including Triage Drugs of Abuse Panel screens, iCup drug test cup, and USD Oral Flui Saliva Test.
- IMI's Offer For Biosite Tops Bid By Beckman Coulter.
Johnson, Holland // BioWorld Today; 4/6/2007, Vol. 18 Issue 67, p1
The article reports on the letter received by Biosite from Inverness Medical Innovations offering to best Beckman Coulter's $1.55 billion bid for its share by $5 a share. It says that the offer came just a day after Beckman initiated its tender offer for Biosite's shares and a little over a week...
- IMI completes Biosite acquisition; Dade Behring grants rights to BC.
Johnson, Holland // Diagnostics & Imaging Week; 7/5/2007, Vol. 10 Issue 27, p3
The article presents an update on deals in the diagnostic equipment industry. Inverness Medical Innovations (IMI) of Waltham, Massachusetts has completed the acquisition of Biosite of San Diego, California. Certain rights have been granted by Dade Behring to Beckman Coulter of Fullerton,...
- Beckman Coulter to buy Biosite in $1.55B proteomics purchase.
Young, Karen // Diagnostics & Imaging Week; 3/29/2007, Vol. 10 Issue 13, p1
The article reports on the merger agreement signed by medical technology developer Beckman Coulter and biomedical company Biosite. According to the author, the agreement covers the acquisition of Biosite's outstanding common stock by Beckman Coulter in a cash tender offer amounting to $1.55...